Cite
HARVARD Citation
Yoshimura, A. et al. (2023). High levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib. Cancer science. 114 (2), pp. 606-618. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yoshimura, A. et al. (2023). High levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib. Cancer science. 114 (2), pp. 606-618. [Online].